How long does pneumonia last
Pro Research Analysisby 
Searched over 200M research papers
Duration and Long-term Impact of Pneumonia
Acute Phase Duration of Pneumonia
Community-Acquired Pneumonia (CAP) in Children
For children aged 2 to 59 months with non-severe community-acquired pneumonia, studies have shown that a short course of antibiotic therapy (three days) is as effective as a longer course (five days) in achieving clinical cure and preventing relapse . This suggests that the acute phase of pneumonia in children can be effectively managed within a week.
Severe Community-Acquired Pneumonia
In cases of severe community-acquired pneumonia, the duration of hospitalization and treatment can be longer. A study involving 58 patients with severe CAP reported that more than 50% of deaths occurred within the first five days due to complications like septic shock and hypoxia, indicating the critical nature of the initial treatment period . However, the overall treatment and recovery period can extend beyond this acute phase, especially in severe cases.
Viral Pneumonia in Infants
For infants under 30 days old with viral pneumonia, the median duration of hospitalization was found to be seven days. This period often involved intensive care measures such as oxygen therapy and mechanical ventilation .
Long-term Impact and Recovery
Long-term Mortality and Morbidity
Patients who survive the acute phase of pneumonia can still face significant long-term health challenges. Studies have shown that long-term mortality rates are higher among pneumonia survivors compared to age-matched controls. Factors such as age, comorbidities, and functional status significantly influence long-term outcomes Mortensen2003Brancati1993. For instance, a study found that 32% of patients who survived the initial hospitalization for CAP died within the next 24 months, with severe comorbidities being a major predictor of mortality .
Recurrent Pneumonia
Recurrent pneumonia is a common issue among survivors. A study tracking patients over five years found that 9% of those who survived an initial CAP episode experienced recurrent pneumonia, with a median time to recurrence of 317 days . Older age and impaired functional status were significant risk factors for recurrence.
Functional Impairments Post-Pneumonia
In the context of COVID-19 pneumonia, more than half of the patients exhibited abnormal lung function 30 days post-infection, highlighting the need for systematic and long-term follow-up . This suggests that even after the acute symptoms resolve, patients may continue to experience significant respiratory issues.
Conclusion
The duration of pneumonia can vary significantly based on the severity and type of infection. While the acute phase can last from a few days to a week, especially in children, severe cases may require longer hospitalization and intensive care. Long-term impacts, including increased mortality, recurrent pneumonia, and functional impairments, underscore the importance of ongoing medical follow-up and management even after the initial recovery.
Sources and full results
Most relevant research papers on this topic
Long-term survival following pneumococcal pneumonia.
Long-term survival after pneumococcal pneumonia is poor, with increased mortality up to 10 years, particularly in those with bacteremic disease and higher PORT scores at admission.
DOI
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.
Long-term mortality in pneumonia patients is significantly higher than in age-matched controls, with factors like age, do-not-resuscitate status, poor nutritional status, pleural effusion, glucocorticoid use, nursing home residence, and low education level being significant risk factors.
DOI
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
More than half of COVID-19 pneumonia patients exhibit abnormal lung function 30 days after symptom onset, highlighting the need for systematic and long-term follow-up.
Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
A short course (three days) of antibiotic therapy is as effective as a longer treatment (five days) for non-severe pneumonia in children under five years of age.
Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up.
Recurrent pneumonia is common in patients with community-acquired pneumonia, particularly in those over 75 and with impaired functional status.
DOI